(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Ryanair, Vertex Pharmaceuticals, and Celanese's Earnings Preview

  • November 04th, 2023
  • 388 views

On Monday, November 6, several notable companies are set to disclose their financial reports, including:

Ryanair Holdings plc (Nasdaq: RYAAY), a leading international airline, is poised to reveal its second-quarter and first-half fiscal 2024 financial results before the market opens.

Analysts predict earnings per share (EPS) of $7.15 on revenue totaling $5.1 billion.

$RYAAY closed at $94.29 on Friday, reflecting an increase of $0.81 (+0.87%).

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX), a prominent pharmaceutical firm, will release its third-quarter 2023 financial results after the financial markets close.

The consensus EPS is estimated at $3.98 with expected revenue of $2.5 billion.

On Friday, $VRTX closed at $376.20, down $0.35 (-0.09%).

Celanese Corporation (NYSE: CE), a global technology and specialty materials company, is expected to announce its third quarter 2023 earnings after the New York Stock Exchange closes.

Analysts project an EPS of $2.23 on revenue amounting to $2.77 billion.

$CE closed at $120.96 on Friday, up $5.39 (+4.66%).

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13